» Articles » PMID: 20477752

Ghrelin Increases Intake of Rewarding Food in Rodents

Overview
Journal Addict Biol
Specialty Psychiatry
Date 2010 May 19
PMID 20477752
Citations 119
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated whether ghrelin action at the level of the ventral tegmental area (VTA), a key node in the mesolimbic reward system, is important for the rewarding and motivational aspects of the consumption of rewarding/palatable food. Mice with a disrupted gene encoding the ghrelin receptor (GHS-R1A) and rats treated peripherally with a GHS-R1A antagonist both show suppressed intake of rewarding food in a free choice (chow/rewarding food) paradigm. Moreover, accumbal dopamine release induced by rewarding food was absent in GHS-R1A knockout mice. Acute bilateral intra-VTA administration of ghrelin increased 1-hour consumption of rewarding food but not standard chow. In comparison with sham rats, VTA-lesioned rats had normal intracerebroventricular ghrelin-induced chow intake, although both intake of and time spent exploring rewarding food was decreased. Finally, the ability of rewarding food to condition a place preference was suppressed by the GHS-R1A antagonist in rats. Our data support the hypothesis that central ghrelin signaling at the level of the VTA is important for the incentive value of rewarding food.

Citing Articles

Intranasal Delivery of a Ghrelin Mimetic Engages the Brain Ghrelin Signaling System in Mice.

Poelman R, Le May M, Schele E, Stoltenborg I, Dickson S Endocrinology. 2025; 166(3).

PMID: 39813130 PMC: 11795113. DOI: 10.1210/endocr/bqae166.


Ghrelin Recruits the Endocannabinoid System to Modulate Food Reward.

Edwards A, DeSante S, Spencer C, Hyland L, Smith A, Sankhe A J Neurosci. 2025; 45(9).

PMID: 39779372 PMC: 11867019. DOI: 10.1523/JNEUROSCI.1620-24.2024.


A randomized, double-blind, placebo-controlled study of a GHSR blocker in people with alcohol use disorder.

Faulkner M, Farokhnia M, Lee M, Farinelli L, Browning B, Abshire K JCI Insight. 2024; 9(24).

PMID: 39704175 PMC: 11665556. DOI: 10.1172/jci.insight.182331.


Ghrelin in Depression: A Promising Therapeutic Target.

Kore M, Mamsa R, Patil D, Bhatt L Mol Neurobiol. 2024; 62(4):4237-4249.

PMID: 39424690 DOI: 10.1007/s12035-024-04554-1.


LEAP2, a ghrelin receptor inverse agonist, and its effect on alcohol-related responses in rodents.

Tufvesson-Alm M, Aranas C, Blid Skoldheden S, Vestlund J, Edvardsson C, Jerlhag E Transl Psychiatry. 2024; 14(1):401.

PMID: 39358354 PMC: 11446955. DOI: 10.1038/s41398-024-03136-y.


References
1.
Moulin A, Demange L, Berge G, Gagne D, Ryan J, Mousseaux D . Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations. J Med Chem. 2007; 50(23):5790-806. DOI: 10.1021/jm0704550. View

2.
Jerlhag E, Egecioglu E, Dickson S, Douhan A, Svensson L, Engel J . Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict Biol. 2007; 12(1):6-16. DOI: 10.1111/j.1369-1600.2006.00041.x. View

3.
Naleid A, Grace M, Cummings D, Levine A . Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens. Peptides. 2005; 26(11):2274-9. DOI: 10.1016/j.peptides.2005.04.025. View

4.
Howard A, Feighner S, Cully D, Arena J, Liberator P, Rosenblum C . A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 1996; 273(5277):974-7. DOI: 10.1126/science.273.5277.974. View

5.
Richardson N, Gratton A . Changes in medial prefrontal cortical dopamine levels associated with response-contingent food reward: an electrochemical study in rat. J Neurosci. 1998; 18(21):9130-8. PMC: 6793513. View